Biopharma Outsourcing Performance
Q3, 2010
This report, Biopharma Outsourcing Performance, examines the outsourcing relationship from the CRO's perspective and benchmarks 53 sponsor companies' outsourcing operations and practices, as well as provides metrics for short, average, and extended timelines for critical stages in the outsourcing decision process.
Companies are benchmarked on factors including
|
|
Report Content:This report contains the following three sections. 1. Positive Biopharma Performance 2. Turnaround Metrics 3. The Service Provider’s View
|
Sample Graph:
|
|
As always, an appendix of Charts and Graphs is also included within this report with responses to all questions asked in this study. |
|
What Readers Will Learn:
Service Providers will benefit from understanding competitive strategies for differentiating themselves in the crowded and competitive CRO market.
- Which attributes your peers think are most important to your customers
- The turnaround time metrics around four parts of a RFP response (submission, bid defense, award notification, contract)
- How your peers trying to differentiate themselves
Biopharmaceutical Companies will receive the data they need to optimize their outsourcing processes, potentially saving millions by shortening timelines and beginning an important relationship with greater chances of success.
- Industry average turnaround metrics to gauge your performance
- Which sponsor companies (by size segment) are viewed as industry leading on seven performance metrics
- Business models CROs are using to differentiate themselves
- CRO views on patient recruitment delays
Similar Reports
Purchasers of this report also purchased:
- 2011 CRO Quality Benchmarking
- The Voice of the Site Coordinator
- Patient and Investigator Recruitment Success
